Gastrointestinal Enzymes Inhibitors from Medicinal Herbs and Food Plants as Therapeutic Pharmacophores for the Management of Diabetes
Journal: Gastro: Open Access (Vol.2, No. 1)Publication Date: 2014-08-01
Authors : Mahomoodally Mohamad Fawzi;
Page : 1-5
Keywords : ;
Abstract
It is a known fact that carbohydrates are the core constituents of the human diet which consist mainly of complex sugars (starch ~60%), and disaccharides (sucrose ~30%). These complex carbohydrates cannot be absorbed unless they are first broken down by gastrointestinal enzymes (amylases, glycosidase and lipases) before they can be transported through the mucosa of the gastrointestinal tract into the circulatory system. α-Amylase is present in both salivary and pancreatic intestinal secretions for hydrolyzing starch and large malto-oligosaccharides to maltose, which is further broken down by α-glucosidase to glucose prior to absorption in the small intestine
Other Latest Articles
- A Novel Approach for the Management of Diabetes Mellitus
- Prevalence of Chronic Kidney Disease in Unselected Swedish Patients with Type 2 Diabetes and its Association with Cardiovascular Disease
- Circulating Endothelial-Derived Apoptotic Microparticles as Novel Perspective Biomarker for Diabetes
- Paternal Influence on Glycemic Control at Baseline and One Year Post Diagnosis in Children and Adolescents with Type 1 Diabetes Mellitus
- Sex Disparity in Cardiovascular Mortality in Patient with EndStage Renal Disease and Type 2 Diabetes Mellitus
Last modified: 2018-10-04 16:05:36